Market Cap
$366.7M
CTEV
Claritev Corp
$21.44 ▲ +0.61%
Prev close $21.31Market cap$366.7M
ConsensusStrong Buy
12-mo target$46.00 (+114.6%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (2 insiders)High Impact Filing (7/10)18 New Institutional Positions8 Institutional Exits Software & IT
Snapshot
The big-picture read on CTEV right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Strong Buy (83%)
Inst. Holders
50 funds
Inst. Value
$160.8M
Inst. Activity
18 buys / 8 sells
Insider Activity
$1.0M buy / $919.3K sell
Insider Net $
$104.0K
SEC Reports
10
Price chart 30d -46.7%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 21, 2026 Insider
Garis Douglas Michael sold 7,877 shares
EVP&CFO @ $30.50 ($240.3K)
Sep 21, 2026 Insider
Sep 15, 2026 SEC Garis Douglas Michael sold 1,148 shares
EVP&CFO @ $31.19 ($35.8K)
Claritev appointed Ben Letham, a Meta research scientist and AI expert, to its Board of Directors to fill a vacancy. The
8-K — Impact 3/10
Sep 14, 2026 Insider
Letham Thomas Benjamin was granted 2,880 shares
Director
Sep 2, 2026 ftd
Aug 18, 2026 SEC FTD: CTEV — 17,477 shares ($0.7M) failed to deliver
Settlement: 20260902, Price: $39.35, FTD Value: $687,719.95, CLARITEV CORPORATION
Two SVP-level insiders at Claritev sold a combined $643K in open-market sales over a 5-day window following the company'
CLUSTER — Impact 3/10
Claritev reported Q2 2026 revenue of $257.5M (+6.6% YoY) and an Adjusted EBITDA of $155.8M (+1.1% YoY), beating expectat
8-K — Impact 6/10
Jun 30, 2026 Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — TRIM
167,006 shares ($5.7M)
Analyst ratings buy % -6.7%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
83% rate it Buy or better · 12 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 21, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| Aug 12, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Aug 10, 2026 | Citigroup | MAINTAIN | Buy | 55% |
| Aug 10, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| Jul 21, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| May 29, 2026 | Canaccord Genuity | INITIATE | Buy | 47% |
| Apr 24, 2026 | Barclays | INITIATE | Overweight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 6 | 2 | 0 | 0 | 83% | |
| Aug 1, 2026 | 4 | 6 | 2 | 0 | 0 | 83% | |
| Jul 1, 2026 | 4 | 6 | 2 | 0 | 0 | 83% | |
| Jun 1, 2026 | 4 | 6 | 2 | 0 | 0 | 83% | |
| May 1, 2026 | 4 | 5 | 2 | 0 | 0 | 82% | |
| Apr 1, 2026 | 4 | 5 | 2 | 0 | 0 | 82% | |
| Mar 1, 2026 | 4 | 5 | 2 | 0 | 0 | 82% | |
| Feb 1, 2026 | 4 | 5 | 2 | 0 | 0 | 82% |
Price targets
Where 5 covering analysts think CTEV trades over the next 12 months.
$46.00 +114.6% upside Strong Buy
Current$21.44 Low$30.00 Median$43.00 High$73.00 5 analysts
$30.00$73.00
Analyst rating Buy· 1.8/5 as of Oct 2, 2026
Social media sentiment
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
10 SEC filing reports analyzed · 5 bullish, 1 bearish, 1 mixed, 3 neutral · avg impact 4.9/10.
NEUTRAL8-K3/10
Claritev appointed Ben Letham, a Meta research scientist and AI expert, to its Board of Directors to
Sep 15, 2026
NEUTRALCLUSTER3/10
Two SVP-level insiders at Claritev sold a combined $643K in open-market sales over a 5-day window fo
Aug 18, 2026
BULLISH8-K6/10
Claritev reported Q2 2026 revenue of $257.5M (+6.6% YoY) and an Adjusted EBITDA of $155.8M (+1.1% Yo
Aug 7, 2026
BULLISH8-K6/10
Claritev Corp disclosed that the DOJ Antitrust Division has closed its grand jury investigation into
Jun 23, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 2, 2026
ftd
FTD: CTEV — 17,477 shares ($0.7M) failed to deliver
Settlement: 20260902, Price: $39.35, FTD Value: $687,719.95, CLARITEV CORPORATION
Aug 18, 2026
ftd
FTD: CTEV — 14,655 shares ($0.5M) failed to deliver
Settlement: 20260818, Price: $35.35, FTD Value: $518,054.25, CLARITEV CORPORATION
Aug 7, 2026
earnings_calendar
CTEV Q2 2026 Earnings Scheduled — 2026-08-07
Jul 21, 2026
other
Claritev Adopts CodeTogether's AITrax to Bring Greater Measurement and Accountability to AI-Assisted Development
Claritev will use CodeTogether's AITrax to help measure adoption, cost, quality, and value across its enterprise AI-assisted software development init
May 18, 2026
short_volume
Short Volume: CTEV — 55.8% short (0.3M / 0.5M)
Short: 283,526 | Exempt: 19,539 | TRF Vol: 508,142 | Short Ratio: 55.8% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $1.71 | $1.71–$1.71 | — | +8.2% | 1↑ 0↓ | $0.3B | 1 |
| Next Q | $1.72 | $1.72–$1.72 | 153.9% | +1.2% | 1↑ 0↓ | $0.3B | 1 |
| Current FY | $5.81 | $5.81–$5.81 | 146.2% | +4.1% | 1↑ 0↓ | $1.0B | 1 |
| Next FY | $7.33 | $7.33–$7.33 | 26.2% | +7.2% | 1↑ 0↓ | $1.1B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $1.710 | — |
| 7d ago | $1.580 | +0.130 |
| 30d ago | $1.580 | +0.130 |
| 60d ago | $1.580 | +0.130 |
| 90d ago | $1.410 | +0.300 |
Institutional ownership
Which big funds own CTEV (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $160.8M total value (4,719,115 shares) as of 2026-Q2. Top holders: PUBLIC, BlackRock,, VANGUARD. Net buying activity: 18 institutions added/increased vs 8 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| PUBLIC INVESTMENT FUND | 1,281,250 | $43.7M | 27.2% | — |
| BlackRock, Inc. | 723,217 | $24.7M | 15.3% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 423,039 | $14.4M | 9.0% | — |
| PRUDENTIAL FINANCIAL INC | 353,904 | $12.1M | 7.5% | ADD +26.6% |
| GEODE CAPITAL MANAGEMENT, LLC | 225,151 | $7.7M | 4.8% | — |
| AQR CAPITAL MANAGEMENT LLC | 174,011 | $5.9M | 3.7% | DOUBLED +225.6% |
| STATE STREET CORP | 170,395 | $5.8M | 3.6% | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 167,006 | $5.7M | 3.5% | TRIM -28.0% |
| NOMURA HOLDINGS INC | 131,760 | $4.5M | 2.8% | — |
| BANK OF AMERICA CORP /DE/ | 93,714 | $3.2M | 2.0% | DOUBLED +146.6% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | TRIM | 232,088 | 167,006 | -28.0% | $5.7M |
| Allianz Asset Management GmbH | ADD | 67,067 | 91,773 | +36.8% | $3.1M |
| Point72 Asset Management, L.P. | TRIM | 89,444 | 39,000 | -56.4% | $1.3M |
| GOLDMAN SACHS GROUP INC | ADD | 15,447 | 27,024 | +74.9% | $921.8K |
| Bank of New York Mellon Corp | ADD | 18,111 | 26,750 | +47.7% | $912.4K |
| MORGAN STANLEY | NEAR_EXIT | 97,055 | 21,460 | -77.9% | $732.0K |
| MARSHALL WACE, LLP | NEAR_EXIT | 70,969 | 13,533 | -80.9% | $461.6K |
| BARCLAYS PLC | NEAR_EXIT | 241,783 | 11,558 | -95.2% | $394.2K |
| MILLENNIUM MANAGEMENT LLC | TRIM | 19,360 | 9,936 | -48.7% | $338.9K |
| DEUTSCHE BANK AG\ | ADD | 5,272 | 9,589 | +81.9% | $327.1K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
17 insiders, 50 transactions. Net $104.0K — $1.0M bought, $919.3K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Garis Douglas Michael | EVP&CFO | SELL | 7,877 | $30.50 | $240.3K |
| Sep 21, 2026 | Garis Douglas Michael | EVP&CFO | SELL | 1,148 | $31.19 | $35.8K |
| Sep 14, 2026 | Letham Thomas Benjamin | Director | AWARD | 2,880 | — | — |
| Aug 28, 2026 | Dalton Travis | Pres., CEO & Executive Chair | BUY | 1,950 | $38.48 | $75.0K |
| Aug 27, 2026 | Dalton Travis | Pres., CEO & Executive Chair | BUY | 4,500 | $38.81 | $174.6K |
| Aug 14, 2026 | Misencik Tiffani | SVP, Chief Growth Officer | SELL | 8,850 | $40.07 | $354.6K |
| Aug 10, 2026 | Mintz William B. | SVP, Chief Strategy Officer | SELL | 8,431 | $34.24 | $288.7K |
| Aug 5, 2026 | Mintz William B. | SVP, Chief Strategy Officer | TAX W/H | 3,622 | $26.13 | $94.6K |
| Aug 5, 2026 | Garis Douglas Michael | EVP&CFO | TAX W/H | 11,711 | $26.13 | $306.0K |
| Jun 30, 2026 | Albinson Brock | SVP, Chief Accounting Officer | AWARD | 3,649 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CTEV.
Shares short
941,196
Settlement Sep 15, 2026
Change vs prior
+2.5%
Semi-monthly cycle
Days to cover
8.6
At avg daily volume
Of shares outstanding
≈5.5%
Estimate — not % of float
All CTEV filing & press-release reports (10)
- 8-K reportSep 15, 2026
- CLUSTER reportAug 18, 2026
- 8-K reportAug 7, 2026
- 8-K reportJun 23, 2026
- 8-K reportMay 18, 2026
- 8-K reportMay 7, 2026
- DEFA14A reportMar 20, 2026
- CLUSTER reportMar 16, 2026
- CLUSTER reportMar 3, 2026
- CLUSTER reportMar 2, 2026